abstract |
The present invention provides a peptide compound Pyr-Gly-Pro-Trp as a therapeutic agent for the prevention and / or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, cardiovascular diseases and metabolic diseases. -Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH 2 . In addition, the present invention optionally comprises a peptide Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-, in combination with at least one pharmaceutically acceptable carrier, antifreeze, lyophilizer, excipient and / or diluent. A pharmaceutical composition containing Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH 2 , preferably in the form of a lyophilizate or liquid buffer or artificial breast milk preparation or breast milk substitute. |